155 related articles for article (PubMed ID: 30034553)
21. Thyroid-stimulating hormone receptor affects metastasis and prognosis in papillary thyroid carcinoma.
Liu TR; Su X; Qiu WS; Chen WC; Men QQ; Zou L; Li ZQ; Fu XY; Yang AK
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3582-91. PubMed ID: 27649658
[TBL] [Abstract][Full Text] [Related]
22. BRAFV600E, BANCR, miR-203a-3p and miR-204-3p in Risk Stratification of PTC Patients.
Stojanović S; Šelemetjev S; Đorić I; Janković Miljuš J; Tatić S; Živaljević V; Išić Denčić T
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137560
[TBL] [Abstract][Full Text] [Related]
23. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma.
Romitti M; Wajner SM; Ceolin L; Ferreira CV; Ribeiro RV; Rohenkohl HC; Weber Sde S; Lopez PL; Fuziwara CS; Kimura ET; Maia AL
Endocr Relat Cancer; 2016 Mar; 23(3):135-46. PubMed ID: 26825960
[TBL] [Abstract][Full Text] [Related]
24. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial Respiration Inhibition Suppresses Papillary Thyroid Carcinoma
Chen B; Lei S; Yin X; Fei M; Hu Y; Shi Y; Xu Y; Fu L
Front Oncol; 2022; 12():900444. PubMed ID: 35865479
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer.
Zeng F; Huang L; Cheng X; Yang X; Li T; Feng G; Tang Y; Yang Y
Cancer Cell Int; 2018; 18():151. PubMed ID: 30302058
[TBL] [Abstract][Full Text] [Related]
27. [Knockdown of cyclin A2 expression by small interfering RNA in MG-63 cells].
Liu Y; Ding JY; Shen WL; Zhao X; Fan SW
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):670-5. PubMed ID: 18246796
[TBL] [Abstract][Full Text] [Related]
28. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of BRAF-activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells.
Li J; Wang J; Zhou W; Zhang S; Le Y; He R
Oncol Lett; 2017 Oct; 14(4):4751-4757. PubMed ID: 29085476
[TBL] [Abstract][Full Text] [Related]
30. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway.
Zhang H; Hu N
Mol Med Rep; 2018 Aug; 18(2):1345-1352. PubMed ID: 29901196
[TBL] [Abstract][Full Text] [Related]
31. Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.
Mon SY; Riedlinger G; Abbott CE; Seethala R; Ohori NP; Nikiforova MN; Nikiforov YE; Hodak SP
Diagn Cytopathol; 2018 May; 46(5):369-377. PubMed ID: 29516685
[TBL] [Abstract][Full Text] [Related]
32. [siRNA-cyclin D1 inhibit cell proliferation in breast cancer MCF-7 cell line].
Jiang L; Chen RS; Li JC
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Apr; 39(2):118-22. PubMed ID: 16944582
[TBL] [Abstract][Full Text] [Related]
33. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
34. [Effect of silencing AEG-1 with small interfering RNA on the proliferation and cell cycle of gastric carcinoma SGC-7901 cells].
Zhang CF; Xia YH; Zheng QF; Li ZJ; Guo XH; Zhou HC; Zhang LL; Dong LP; Han Y; Liu ZE; Wang WJ; Luo YL
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):22-7. PubMed ID: 23648295
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of BRAF-activated non-protein coding RNA in patients with hepatitis B virus-associated hepatocellular carcinoma.
Zhao NN; Wang C; Lai CC; Cheng SJ; Yan J; Hong ZX; Yu LX; Zhu ZY; Zhang PR; Wang ZH; Wang XL; Zhang SG; Yang PH
Oncol Lett; 2018 May; 15(5):7794-7798. PubMed ID: 29725471
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression.
Nakashima M; Meirmanov S; Naruke Y; Kondo H; Saenko V; Rogounovitch T; Shimizu-Yoshida Y; Takamura N; Namba H; Ito M; Abrosimov A; Lushnikov E; Roumiantsev P; Tsyb A; Yamashita S; Sekine I
J Pathol; 2004 Apr; 202(4):446-55. PubMed ID: 15095272
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway.
Song HM; Song JL; Li DF; Hua KY; Zhao BK; Fang L
Onco Targets Ther; 2015; 8():3565-73. PubMed ID: 26664140
[TBL] [Abstract][Full Text] [Related]
39. High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells.
Fiore AP; Fuziwara CS; Kimura ET
Thyroid; 2009 Nov; 19(11):1249-56. PubMed ID: 19725779
[TBL] [Abstract][Full Text] [Related]
40. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
